{"id":151642,"date":"2025-10-29T15:05:07","date_gmt":"2025-10-29T15:05:07","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/151642\/"},"modified":"2025-10-29T15:05:07","modified_gmt":"2025-10-29T15:05:07","slug":"frequency-of-tuberculosis-symptoms-at-repeat-visits-amongst-adults-attending-for-hiv-care-in-gauteng-province-south-africa-bmc-public-health","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/151642\/","title":{"rendered":"Frequency of tuberculosis symptoms at repeat visits amongst adults attending for HIV care in Gauteng province, South Africa | BMC Public Health"},"content":{"rendered":"
  • \n

    WHO. Global tuberculosis report 2021. Geneva: World Health Organization. 2021. Licence: CC BY-NC-SA 3.0 IGO. 2021. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240037021<\/a>. Cited 10 Feb 2023. <\/p>\n<\/li>\n

  • \n

    WHO. Global tuberculosis report 2023. Geneva: World Health Organization. 2023. Licence: CC BY-NC-SA 3.0 IGO. 2023. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023<\/a>. Cited 7 Jan 2024. <\/p>\n<\/li>\n

  • \n

    World Health Organisation. Systematic screening for active tuberculosis: principles and recommendations. World Health Organization; 2013. https:\/\/books.google.co.za\/books?id=g7EXDAAAQBAJ<\/a><\/p>\n<\/li>\n

  • \n

    Uplekar M, Creswell J, Ottmani SE, Weil D, Sahu S, L\u00f6nnroth K. Programmatic approaches to screening for active tuberculosis. Int J Tuberc Lung Dis. 2013;17(10):1248\u201356.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. World Health Organization. 2013. xv, 79 p. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/112472<\/a>. Cited 10 Feb 2023. <\/p>\n<\/li>\n

  • \n

    National Tuberculosis Management Guidelines. 2014. Available from: https:\/\/www.tbonline.info\/media\/uploads\/documents\/national_tuberculosis_management_guidelines_%282014%29.pdf<\/a>. Cited 10 Feb 2023. <\/p>\n<\/li>\n

  • \n

    Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N et al. An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV. N Engl J Med. 2010;362(8):707\u201316. Available from: https:\/\/doi.org\/10.1056\/NEJMoa0907488<\/a>. Cited 12 Apr 2021.<\/p>\n<\/li>\n

  • \n

    Hanifa Y, Fielding KL, Chihota VN, Adonis L, Charalambous S, Foster N et al. A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa. PLOS ONE. 2017;12(8):e0181519. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0181519<\/a>. Cited 10 Feb 2023. <\/p>\n<\/li>\n

  • \n

    Hanifa Y, Silva ST, Karstaedt A, Sahid F, Charalambous S, Chihota VN et al. What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations? Int J Tuberc Lung Dis. 2019;23(2):157. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6394279\/<\/a>. Cited 10 Feb 2023. <\/p>\n<\/li>\n

  • \n

    Hanifa Y, Fielding KL, Chihota VN, Adonis L, Charalambous S, Foster N et al. The utility of repeat Xpert MTB\/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result. Gates Open Research; 2022 . Available from: https:\/\/gatesopenresearch.org\/articles\/2-22<\/a>. Cited 10 Feb 2023. <\/p>\n<\/li>\n

  • \n

    NICD. Weekly Influenza and Respiratory Syncytial Surveillance Report. NICD. 2013. Available from: https:\/\/www.nicd.ac.za\/publications__trashed\/weekly-influenza-and-respiratory-syncytial-surveillance-report\/<\/a>. Cited 11 Feb 2023.<\/p>\n<\/li>\n

  • \n

    Brennan A, Maskew M, Larson BA, Tsikhutsu I, Bii M, Vezi L et al. Prevalence of TB symptoms, diagnosis and treatment among people living with HIV (PLHIV) not on ART presenting at outpatient clinics in South Africa and Kenya: baseline results from a clinical trial. BMJ Open. 2020;10(9):e035794. Available from: https:\/\/bmjopen.bmj.com\/content\/10\/9\/e035794<\/a>.\u00a0Cited 21 Feb 2023. <\/p>\n<\/li>\n

  • \n

    Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, van Cutsem G, Goliath R et al. Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV Clinic. Clin Infect Dis. 2012;55(12):1698\u2013706. Available from: https:\/\/doi.org\/10.1093\/cid\/cis775<\/a>. Cited 21 Feb 2023. <\/p>\n<\/li>\n

  • \n

    Rie AV, Clouse K, Hanrahan C, Selibas K, Sanne I, Williams S et al. High Uptake of Systematic HIV Counseling and Testing and TB Symptom Screening at a Primary Care Clinic in South Africa. PLOS ONE. 2014;9(9):e105428. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0105428<\/a>. Cited 21 Feb 2023. <\/p>\n<\/li>\n

  • \n

    Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009;23(13):1717. Available from: https:\/\/journals.lww.com\/aidsonline\/abstract\/2009\/08240\/short_term_and_long_term_risk_of_tuberculosis.11.aspx<\/a>.\u00a0Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29(15):1987. Available from: https:\/\/journals.lww.com\/aidsonline\/fulltext\/2015\/09240\/Prevalence_of_tuberculosis_in_post_mortem_studies.12.aspx<\/a>. Cited 27 Jul 2025.<\/p>\n<\/li>\n

  • \n

    Reid A, Scano F, Getahun H, Williams B, Dye C, Nunn P et al. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis\/HIV collaboration. Lancet Infect Dis. 2006;6(8):483\u201395. Available from: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473309906705497\/abstract<\/a>.\u00a0Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White ACJ et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19(4):399. Available from: https:\/\/journals.lww.com\/aidsonline\/abstract\/2005\/03040\/incidence_and_risk_factors_for_immune.5.aspx<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN et al. Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa. PLOS ONE. 2013;8(1):e55305. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0055305<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516\u201323. Available from: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473309908701841\/abstract<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Pawlowski A, Jansson M, Sk\u00f6ld M, Rottenberg ME, K\u00e4llenius G, Tuberculosis, Co-Infection HIV. PLOS Pathog. 2012;8(2):e1002464. Available from: https:\/\/journals.plos.org\/plospathogens\/article?id=10.1371\/journal.ppat.1002464<\/a>.\u00a0Cited 27 Jul 2025.<\/p>\n<\/li>\n

  • \n

    Getahun H, Harrington M, O\u2019Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. The Lancet. 2007;369(9578):2042\u20139. Available from: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(07)60284-0\/abstract?is=<\/a>.\u00a0Cited 27 Jul 2025.<\/p>\n<\/li>\n

  • \n

    O\u2019Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Robert Horsburgh C. J. Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection. Emerg Infect Dis. 2013;19(3):416. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3647656\/<\/a>.\u00a0Cited 27 Jul 2025.<\/p>\n<\/li>\n

  • \n

    Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of Tuberculosis From Exposure to Tobacco Smoke: A Systematic Review and Meta-analysis. Arch Intern Med. 2007;167(4):335\u201342. Available from: https:\/\/doi.org\/10.1001\/archinte.167.4.335<\/a>. Cited 27 Jul 2025.<\/p>\n<\/li>\n

  • \n

    Shargie EB. Trends, challenges and opportunities in tuberculosis control in rural Ethiopia. 2006; Available from: https:\/\/www.researchgate.net\/profile\/Estifanos-Shargie\/publication\/255590195_Trends_challenges_and_opportunities_in_tuberculosis_control_in_rural_Ethiopia\/links\/59034b2a4585152d2e92e606\/Trends-challenges-and-opportunities-in-tuberculosis-control-in-rural-Ethiopia.pdf<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Horton KC, Sumner T, Houben RMGJ, Corbett EL, White RG. A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease Burden. Am J Epidemiol. 2018;187(11):2431\u20138. Available from: https:\/\/doi.org\/10.1093\/aje\/kwy131<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Dowdy DW, Cattamanchi A, Steingart KR, Pai M. Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis. PLOS Med. 2011;8(7):e1001063. Available from: https:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1001063<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP et al. Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies. PLOS Med. 2011;8(1):e1000391. Available from: https:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1000391<\/a>. Cited 21 Feb 2023. <\/p>\n<\/li>\n

  • \n

    Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP et al. Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies. PLOS Med. 2011;8(1):e1000391. Available from: https:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1000391<\/a>.\u00a0Cited 27 July 2025. <\/p>\n<\/li>\n

  • \n

    Kufa T, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant AD et al. Undiagnosed Tuberculosis Among HIV Clinic Attendees: Association With Antiretroviral Therapy and Implications for Intensified Case Finding, Isoniazid Preventive Therapy, and Infection Control. JAIDS J Acquir Immune Defic Syndr. 2012;60(2):e22. Available from: https:\/\/journals.lww.com\/jaids\/fulltext\/2012\/06010\/Undiagnosed_Tuberculosis_Among_HIV_Clinic.11.aspx<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Yoon C, Semitala FC, Atuhumuza E, Katende J, Mwebe S, Asege L et al. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study. Lancet Infect Dis. 2017;17(12):1285\u201392. Available from: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(17)30488-7\/abstract<\/a>.\u00a0Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA et al. The cost-effectiveness of routine tuberculosis screening with Xpert MTB\/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS. 2012;26(8):987. Available from: https:\/\/journals.lww.com\/aidsonline\/abstract\/2012\/05150\/the_cost_effectiveness_of_routine_tuberculosis.10.aspx<\/a>. Cited 27 Jul 2025. <\/p>\n<\/li>\n

  • \n

    Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D et al. Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis. PLOS Med. 2012;9(7):e1001270. Available from: https:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1001270<\/a>. Cited 12 Apr 2021. <\/p>\n<\/li>\n

  • \n

    Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, van Cutsem G, Goliath R et al. Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV Clinic. Clin Infect Dis. 2012;55(12):1698\u2013706. Available from: https:\/\/doi.org\/10.1093\/cid\/cis775<\/a>.\u00a0Cited 25 Jul 2021. <\/p>\n<\/li>\n

  • \n

    Khan FA, Verkuijl S, Parrish A, Chikwava F, Ntumy R, El-Sadr W et al. Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped. AIDS Lond Engl. 2014;28(10):1463\u201372. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5116236\/<\/a>. Cited 25 Jul 2021. <\/p>\n<\/li>\n

  • \n

    Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX, Kredo T, et al. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis. 2022;22(4):507\u201318.\u00a0Available from:\u00a0https:\/\/www.thelancet.com\/article\/S1473-3099(21)00387-X\/fulltext<\/a>.\u00a0Cited 27 Jul 2025.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Cohen C, Kleynhans J, Moyes J, McMorrow ML, Treurnicht FK, Hellferscee O, et al. Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017\u201318 (PHIRST): a population cohort study. Lancet Glob Health. 2021;9(6):e863-74.\u00a0Available from:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2214109X21001418<\/a>. Cited 25 Jul 2021.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tedijanto C, Hermans S, Cobelens F, Wood R, Andrews JR. Drivers of seasonal variation in tuberculosis incidence: insights from a systematic review and mathematical model. Epidemiol Camb Mass. 2018;29(6):857\u201366. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6167146\/<\/a>. Cited 25 Jul 2021. <\/p>\n<\/li>\n

  • \n

    The South African Antiretroviral Treatment Guidelines. Final 25 March 2013 corrected. Available from: https:\/\/sahivsoc.org\/Files\/2013%20ART%20Treatment%20Guidelines%20Final%2025%20March%202013%20corrected.pdf<\/a>.\u00a0Cited 21 Feb 2023.<\/p>\n<\/li>\n

  • \n

    NDoD. National Consolidated Guidelines for the Management of HIV and PMTCT. 2020. TB HIV Informational Systems Support Portal. 2020. Available from: https:\/\/www.tbhivinfosys.org.za\/doc\/national-consolidated-guidelines-for-the-management-of-hiv-and-pmtct-2020\/<\/a>. Cited 21 Feb 2023.<\/p>\n<\/li>\n

  • \n

    HERO. 2022. Does differentiated service delivery for HIV treatment change healthcare providers workload? Provider views from Malawi, South Africa, and Zambia. Available from: https:\/\/www.heroza.org\/wp-content\/uploads\/2022\/07\/Phiri-Providers-Workload_AIDS-2022-Abstract-Submission_Bevis.pdf<\/a>.\u00a0Cited 21 Feb 2023.<\/p>\n<\/li>\n

  • \n

    Huber A, Pascoe S, Nichols B, Long L, Kuchukhidze S, Phiri B, et al. Differentiated Service Delivery Models for HIV Treatment in Malawi, South Africa, and Zambia: A Landscape Analysis. Glob Health Sci Pract. 2021;9(2):296\u2013307.\u00a0Available from:\u00a0https:\/\/www.ghspjournal.org\/content\/9\/2\/296<\/a>. Cited 21 Feb 2023.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n","protected":false},"excerpt":{"rendered":"WHO. Global tuberculosis report 2021. Geneva: World Health Organization. 2021. Licence: CC BY-NC-SA 3.0 IGO. 2021. Available from:…\n","protected":false},"author":2,"featured_media":151643,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[78],"tags":[8750,18,3015,3026,910,135,19,17,7482,29312,2101,5258,88843,8660,88844,88845],"class_list":{"0":"post-151642","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-biostatistics","9":"tag-eire","10":"tag-environmental-health","11":"tag-epidemiology","12":"tag-general","13":"tag-health","14":"tag-ie","15":"tag-ireland","16":"tag-medicine-public-health","17":"tag-plhiv","18":"tag-public-health","19":"tag-south-africa","20":"tag-tb-case-finding","21":"tag-vaccine","22":"tag-w4ss-symptom-screening","23":"tag-xpert-mtb-rif"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115458075711301938","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/151642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=151642"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/151642\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/151643"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=151642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=151642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=151642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}